CAMP4 Enterprise Value Over E B I T D A from 2010 to 2024
| CAMP Stock | USD 5.41 0.37 6.40% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 495.09313191 | Current Value 535.9 | Quarterly Volatility 3.4 K |
Check CAMP4 THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CAMP4 THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17.8 M, Interest Expense of 8.3 M or Selling General Administrative of 36.9 M, as well as many indicators such as Price To Sales Ratio of 1.4, Ptb Ratio of 70.11 or Capex To Depreciation of 0.84. CAMP4 financial statements analysis is a perfect complement when working with CAMP4 THERAPEUTICS Valuation or Volatility modules.
CAMP4 | Enterprise Value Over E B I T D A |
Latest CAMP4 THERAPEUTICS's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of CAMP4 THERAPEUTICS PORATION over the last few years. It is CAMP4 THERAPEUTICS's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CAMP4 THERAPEUTICS's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
CAMP4 Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 1,408 | |
| Geometric Mean | 632.16 | |
| Coefficient Of Variation | 239.29 | |
| Mean Deviation | 1,621 | |
| Median | 535.90 | |
| Standard Deviation | 3,368 | |
| Sample Variance | 11.3M | |
| Range | 13.3K | |
| R-Value | 0.31 | |
| Mean Square Error | 11M | |
| R-Squared | 0.1 | |
| Significance | 0.26 | |
| Slope | 233.10 | |
| Total Sum of Squares | 158.8M |
CAMP4 Enterprise Value Over E B I T D A History
About CAMP4 THERAPEUTICS Financial Statements
CAMP4 THERAPEUTICS shareholders use historical fundamental indicators, such as Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although CAMP4 THERAPEUTICS investors may analyze each financial statement separately, they are all interrelated. The changes in CAMP4 THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses on on CAMP4 THERAPEUTICS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 495.09 | 535.90 |
Pair Trading with CAMP4 THERAPEUTICS
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.Moving against CAMP4 Stock
| 0.73 | VINC | Vincerx Pharma | PairCorr |
| 0.51 | DTIL | Precision BioSciences | PairCorr |
| 0.44 | DRTS | Alpha Tau Medical | PairCorr |
| 0.38 | DRMA | Dermata Therapeutics | PairCorr |
| 0.32 | VIRX | Viracta Therapeutics | PairCorr |
The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.
The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.